When Should a Positive Surgical Margin Ring a Bell? An Analysis of a Multi-Institutional Robot-Assisted Laparoscopic Radical Prostatectomy Database

Firas Abdollah, Marco Moschini, Akshay Sood, Jesse Sammon, Deepansh Dalela, Linda Hsu, Burkhard Beyer, Alexander Haese, Markus Graefen, Giorgio Gandaglia, Francesco Montorsi, Alberto Briganti, Mani Menon

Research output: Contribution to journalArticle

Abstract

Objective: The impact of positive surgical margin (SM) on cancer control outcomes in prostate cancer patients is a subject of continuous debate. We test the hypothesis that the impact of SM on clinical recurrence (CR) rate may vary based on the other clinical/pathologic characteristics of the tumor. Materials and Methods: We focused on 5290 patients treated with robot-assisted radical prostatectomy and pelvic node dissection, between 2002 and 2013, at three tertiary care centers. Regression tree analysis stratified patients into risk groups based on their tumor characteristics and the corresponding CR rate. Kaplan-Meier log-rank and multivariable Cox regression models tested the relationship between SM status and CR rate in each tree-generated risk group. Results: Mean (median) follow-up time was 47.7 (39.0) months. Regression tree analysis that considered all available covariates, except SM status, divided patients based on their CR risk into the following risk groups: (1) high risk (any pT3b/pT4 disease); (2) intermediate risk (≤pT3a disease and pGS 8-10); (3) low risk (≤pT3a, pGS ≤7, and prostate-specific antigen [PSA] >9 ng/mL); and (4) very low risk (≤pT3a, pGS ≤7, and PSA ≤9 ng/mL). Positive SM had a significant detrimental impact on CR risk only in two groups: intermediate risk (p <0.001) and high risk (p = 0.01). These observations were confirmed by multivariable analyses. Conclusions: Our findings show that positive SM had a detrimental impact on CR only in a minority of patients (15%), specifically in those with advanced pathologic stage and/or pathologically poorly differentiated tumor. For all the remaining patients (85%), positive SM by itself did not increase the risk of CR.

Original languageEnglish
Pages (from-to)201-207
Number of pages7
JournalJournal of Endourology
Volume30
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Prostatectomy
Databases
Recurrence
Prostate-Specific Antigen
Margins of Excision
Neoplasms
Regression Analysis
Proportional Hazards Models
Tertiary Care Centers
Dissection
Prostatic Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

When Should a Positive Surgical Margin Ring a Bell? An Analysis of a Multi-Institutional Robot-Assisted Laparoscopic Radical Prostatectomy Database. / Abdollah, Firas; Moschini, Marco; Sood, Akshay; Sammon, Jesse; Dalela, Deepansh; Hsu, Linda; Beyer, Burkhard; Haese, Alexander; Graefen, Markus; Gandaglia, Giorgio; Montorsi, Francesco; Briganti, Alberto; Menon, Mani.

In: Journal of Endourology, Vol. 30, No. 2, 01.02.2016, p. 201-207.

Research output: Contribution to journalArticle

Abdollah, Firas ; Moschini, Marco ; Sood, Akshay ; Sammon, Jesse ; Dalela, Deepansh ; Hsu, Linda ; Beyer, Burkhard ; Haese, Alexander ; Graefen, Markus ; Gandaglia, Giorgio ; Montorsi, Francesco ; Briganti, Alberto ; Menon, Mani. / When Should a Positive Surgical Margin Ring a Bell? An Analysis of a Multi-Institutional Robot-Assisted Laparoscopic Radical Prostatectomy Database. In: Journal of Endourology. 2016 ; Vol. 30, No. 2. pp. 201-207.
@article{5420f1c21f5f4cd79a4f78f163ef2bb0,
title = "When Should a Positive Surgical Margin Ring a Bell? An Analysis of a Multi-Institutional Robot-Assisted Laparoscopic Radical Prostatectomy Database",
abstract = "Objective: The impact of positive surgical margin (SM) on cancer control outcomes in prostate cancer patients is a subject of continuous debate. We test the hypothesis that the impact of SM on clinical recurrence (CR) rate may vary based on the other clinical/pathologic characteristics of the tumor. Materials and Methods: We focused on 5290 patients treated with robot-assisted radical prostatectomy and pelvic node dissection, between 2002 and 2013, at three tertiary care centers. Regression tree analysis stratified patients into risk groups based on their tumor characteristics and the corresponding CR rate. Kaplan-Meier log-rank and multivariable Cox regression models tested the relationship between SM status and CR rate in each tree-generated risk group. Results: Mean (median) follow-up time was 47.7 (39.0) months. Regression tree analysis that considered all available covariates, except SM status, divided patients based on their CR risk into the following risk groups: (1) high risk (any pT3b/pT4 disease); (2) intermediate risk (≤pT3a disease and pGS 8-10); (3) low risk (≤pT3a, pGS ≤7, and prostate-specific antigen [PSA] >9 ng/mL); and (4) very low risk (≤pT3a, pGS ≤7, and PSA ≤9 ng/mL). Positive SM had a significant detrimental impact on CR risk only in two groups: intermediate risk (p <0.001) and high risk (p = 0.01). These observations were confirmed by multivariable analyses. Conclusions: Our findings show that positive SM had a detrimental impact on CR only in a minority of patients (15{\%}), specifically in those with advanced pathologic stage and/or pathologically poorly differentiated tumor. For all the remaining patients (85{\%}), positive SM by itself did not increase the risk of CR.",
author = "Firas Abdollah and Marco Moschini and Akshay Sood and Jesse Sammon and Deepansh Dalela and Linda Hsu and Burkhard Beyer and Alexander Haese and Markus Graefen and Giorgio Gandaglia and Francesco Montorsi and Alberto Briganti and Mani Menon",
year = "2016",
month = "2",
day = "1",
doi = "10.1089/end.2015.0465",
language = "English",
volume = "30",
pages = "201--207",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - When Should a Positive Surgical Margin Ring a Bell? An Analysis of a Multi-Institutional Robot-Assisted Laparoscopic Radical Prostatectomy Database

AU - Abdollah, Firas

AU - Moschini, Marco

AU - Sood, Akshay

AU - Sammon, Jesse

AU - Dalela, Deepansh

AU - Hsu, Linda

AU - Beyer, Burkhard

AU - Haese, Alexander

AU - Graefen, Markus

AU - Gandaglia, Giorgio

AU - Montorsi, Francesco

AU - Briganti, Alberto

AU - Menon, Mani

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Objective: The impact of positive surgical margin (SM) on cancer control outcomes in prostate cancer patients is a subject of continuous debate. We test the hypothesis that the impact of SM on clinical recurrence (CR) rate may vary based on the other clinical/pathologic characteristics of the tumor. Materials and Methods: We focused on 5290 patients treated with robot-assisted radical prostatectomy and pelvic node dissection, between 2002 and 2013, at three tertiary care centers. Regression tree analysis stratified patients into risk groups based on their tumor characteristics and the corresponding CR rate. Kaplan-Meier log-rank and multivariable Cox regression models tested the relationship between SM status and CR rate in each tree-generated risk group. Results: Mean (median) follow-up time was 47.7 (39.0) months. Regression tree analysis that considered all available covariates, except SM status, divided patients based on their CR risk into the following risk groups: (1) high risk (any pT3b/pT4 disease); (2) intermediate risk (≤pT3a disease and pGS 8-10); (3) low risk (≤pT3a, pGS ≤7, and prostate-specific antigen [PSA] >9 ng/mL); and (4) very low risk (≤pT3a, pGS ≤7, and PSA ≤9 ng/mL). Positive SM had a significant detrimental impact on CR risk only in two groups: intermediate risk (p <0.001) and high risk (p = 0.01). These observations were confirmed by multivariable analyses. Conclusions: Our findings show that positive SM had a detrimental impact on CR only in a minority of patients (15%), specifically in those with advanced pathologic stage and/or pathologically poorly differentiated tumor. For all the remaining patients (85%), positive SM by itself did not increase the risk of CR.

AB - Objective: The impact of positive surgical margin (SM) on cancer control outcomes in prostate cancer patients is a subject of continuous debate. We test the hypothesis that the impact of SM on clinical recurrence (CR) rate may vary based on the other clinical/pathologic characteristics of the tumor. Materials and Methods: We focused on 5290 patients treated with robot-assisted radical prostatectomy and pelvic node dissection, between 2002 and 2013, at three tertiary care centers. Regression tree analysis stratified patients into risk groups based on their tumor characteristics and the corresponding CR rate. Kaplan-Meier log-rank and multivariable Cox regression models tested the relationship between SM status and CR rate in each tree-generated risk group. Results: Mean (median) follow-up time was 47.7 (39.0) months. Regression tree analysis that considered all available covariates, except SM status, divided patients based on their CR risk into the following risk groups: (1) high risk (any pT3b/pT4 disease); (2) intermediate risk (≤pT3a disease and pGS 8-10); (3) low risk (≤pT3a, pGS ≤7, and prostate-specific antigen [PSA] >9 ng/mL); and (4) very low risk (≤pT3a, pGS ≤7, and PSA ≤9 ng/mL). Positive SM had a significant detrimental impact on CR risk only in two groups: intermediate risk (p <0.001) and high risk (p = 0.01). These observations were confirmed by multivariable analyses. Conclusions: Our findings show that positive SM had a detrimental impact on CR only in a minority of patients (15%), specifically in those with advanced pathologic stage and/or pathologically poorly differentiated tumor. For all the remaining patients (85%), positive SM by itself did not increase the risk of CR.

UR - http://www.scopus.com/inward/record.url?scp=84958151680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958151680&partnerID=8YFLogxK

U2 - 10.1089/end.2015.0465

DO - 10.1089/end.2015.0465

M3 - Article

AN - SCOPUS:84958151680

VL - 30

SP - 201

EP - 207

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 2

ER -